Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-17
SponsorDana-Farber Cancer Institute

About this trial

Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot study of a program entitled 'Developing Restful Environments and Management Strategies' (DREAMS). The program will provide children receiving SCT and families with information and a kit that includes tools which may support sleep and circadian health during an inpatient hospitalization.

Eligibility criteria

Qualifiers

Patient aged 9-17 years.

Patient scheduled to receive a stem cell transplant at Boston Children's Hospital.

English speaking child and primary caregiver (parent/guardian).

Disqualifiers

None

Trial design

Treatments tested in this trial

  • DREAMS Program Video and Care Kit

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators

Dana-Farber Cancer Institute

Lead sponsor

American Cancer Society, Inc.

Collaborator